Jianchao X. Si
Shijiazhuang, 050011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MiR-1-3p inhibits mitophagy in esophageal squamous cell carcinoma by targeting SLC7A11
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: July 22, 2025
Shengmaisan combined with Liuwei Dihuang Decoction alleviated CIH-induced glutamate excitotoxicity by IGF1/IGFR signaling pathway.
Journal: Fitoterapia
Published: June 24, 2025
Role of IGF1/IGFR signaling pathway in neuroprotective effect of Shengmai Dihuang Decoction on CIH-induced cognitive impairment.
Journal: Journal of traditional and complementary medicine
Published: March 24, 2024
Shengmaisan combined with Liuwei Dihuang Decoction alleviates chronic intermittent hypoxia-induced cognitive impairment by activating the EPO/EPOR/JAK2 signaling pathway.
Journal: Chinese journal of natural medicines
Published: December 20, 2023
Danggui-Buxue decoction alleviated vascular senescence in mice exposed to chronic intermittent hypoxia through activating the Nrf2/HO-1 pathway.
Journal: Pharmaceutical biology
Published: July 11, 2023
Tanshinone IIA inhibited intermittent hypoxia induced neuronal injury through promoting autophagy via AMPK-mTOR signaling pathway.
Journal: Journal of ethnopharmacology
Published: March 15, 2023
Shashen-Maidong Decoction inhibited cancer growth under intermittent hypoxia conditions by suppressing oxidative stress and inflammation.
Journal: Journal of ethnopharmacology
Published: February 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026